Real-World Outcome for Newly Diagnosed Patients with Functional High-Risk Myeloma - a Myeloma and Related Diseases Registry Analysis

被引：0

作者：

Spencer, Andrew ^{[1
]}

Mollee, Peter ^{[2
]}

Blacklock, Hilary Anne ^{[3
]}

Harrison, Simon ^{[4
,5
]}

Quach, Hang ^{[6
]}

Ho, P. Joy ^{[7
]}

Spearing, Ruth

Hocking, Jay ^{[8
]}

Augustson, Bradley ^{[9
]}

Prince, H. Miles ^{[10
]}

Moore, Elizabeth M. ^{[11
]}

McQuilten, Zoe

Wood, Erica M. ^{[11
]}

Wellard, Cameron

机构：

[1] Monash Univ, Alfred Hlth, Dept Clin Haematol, Melbourne, Vic, Australia

[2] Princess Alexandra Hosp, Dept Haematol, Brisbane, Qld, Australia

[3] Middlemore Hosp, Auckland, New Zealand

[4] Peter MacCallum Canc Ctr, Clin Haematol, Melbourne, Vic, Australia

[5] Royal Melbourne Hosp, Melbourne, Vic, Australia

[6] St Vincents Hosp, Dept Haematol, Melbourne, Vic, Australia

[7] Royal Prince Alfred Hosp, Inst Haematol, Sydney, NSW, Australia

[8] Box Hill Hosp, Dept Haematol, Melbourne, Vic, Australia

[9] Sir Charles Gairdner Hosp, Dept Haematol, Nedlands, WA, Australia

[10] Epworth Freemasons Hosp, Melbourne, Vic, Australia

[11] Monash Univ, Transfus Res Unit, Melbourne, Vic, Australia

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-129431

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

269

引用

页数：4

共 50 条

[31] Is more better in myeloma? Treatment intensity and outcome in newly diagnosed myeloma patients
Fillitz M.
Seebacher A.
Panny M.
[J]. memo - Magazine of European Medical Oncology, 2015, 8 (1) : 22 - 25
[32] PROGNOSTIC IMPLICATIONS OF MULTIPLE CYTOGENETIC HIGH-RISK ABNORMALITIES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
Binder, M.
Rajkumar, S. V.
Ketterling, R. P.
Dispenzieri, A.
Lacy, M. Q.
Gertz, M. A.
Buadi, F. K.
Hayman, S. R.
Hwa, Y. L.
Zeldenrust, S. R.
Lust, J. A.
Russell, S. J.
Leung, N.
Kapoor, P.
Go, R. S.
Gonsalves, W. I.
Kyle, R. A.
Kumar, S. K.
[J]. HAEMATOLOGICA, 2017, 102 : 107 - 107
[33] Prognostic Implications of Multiple Cytogenetic High-Risk Abnormalities in Patients with Newly Diagnosed Multiple Myeloma
Binder, Moritz
Rajkumar, S. Vincent
Ketterling, Rhett P.
Dispenzieri, Angela
Lacy, Martha Q.
Gertz, Morie A.
Buadi, Francis K.
Hayman, Suzanne R.
Hwa, Yi L.
Zeldenrust, Steven R.
Lust, John A.
Russell, Stephen J.
Leung, Nelson
Kapoor, Prashant
Go, Ronald S.
Gonsalves, Wilson I.
Kyle, Robert A.
Kumar, Shaji
[J]. BLOOD, 2016, 128 (22)
[34] A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Brian A. Walker
Konstantinos Mavrommatis
Christopher P. Wardell
T. Cody Ashby
Michael Bauer
Faith Davies
Adam Rosenthal
Hongwei Wang
Pingping Qu
Antje Hoering
Mehmet Samur
Fadi Towfic
Maria Ortiz
Erin Flynt
Zhinuan Yu
Zhihong Yang
Dan Rozelle
John Obenauer
Matthew Trotter
Daniel Auclair
Jonathan Keats
Niccolo Bolli
Mariateresa Fulciniti
Raphael Szalat
Phillipe Moreau
Brian Durie
A. Keith Stewart
Hartmut Goldschmidt
Marc S. Raab
Hermann Einsele
Pieter Sonneveld
Jesus San Miguel
Sagar Lonial
Graham H. Jackson
Kenneth C. Anderson
Herve Avet-Loiseau
Nikhil Munshi
Anjan Thakurta
Gareth Morgan
[J]. Leukemia, 2019, 33 : 159 - 170
[35] A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Walker, Brian A.
Mavrommatis, Konstantinos
Wardell, Christopher P.
Ashby, T. Cody
Bauer, Michael
Davies, Faith
Rosenthal, Adam
Wang, Hongwei
Qu, Pingping
Hoering, Antje
Samur, Mehmet
Towfic, Fadi
Ortiz, Maria
Flynt, Erin
Yu, Zhinuan
Yang, Zhihong
Rozelle, Dan
Obenauer, John
Trotter, Matthew
Auclair, Daniel
Keats, Jonathan
Bolli, Niccolo
Fulciniti, Mariateresa
Szalat, Raphael
Moreau, Phillipe
Durie, Brian
Stewart, A. Keith
Goldschmidt, Hartmut
Raab, Marc S.
Einsele, Hermann
Sonneveld, Pieter
San Miguel, Jesus
Lonial, Sagar
Jackson, Graham H.
Anderson, Kenneth C.
Avet-Loiseau, Herve
Munshi, Nikhil
Thakurta, Anjan
Morgan, Gareth
[J]. LEUKEMIA, 2019, 33 (01) : 159 - 170
[36] Caution With Routine Use of Daratumumab for Newly Diagnosed High-Risk Multiple Myeloma
Mohyuddin, Ghulam Rehman
Abdallah, Al-Ola
McClune, Brian
[J]. JAMA ONCOLOGY, 2021, 7 (04) : 635 - 635
[37] Roundtable: How I treat a newly diagnosed patient with high-risk myeloma
Kaufman, Jonathan L.
[J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 120 - 124
[38] Real-world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database
Mian, Hira
LeBlanc, Richard
Louzada, Martha
Masih-Khan, Esther
McCurdy, Arleigh
Venner, Christopher P.
Stakiw, Julie
Kardjadj, Moustafa
Jimenez-Zepeda, Victor H.
Sebag, Michael
White, Darrell
Aslam, Muhammad
Song, Kevin
Reiman, Anthony
Kotb, Rami
Gul, Engin
Reece, Donna
[J]. CANCER MEDICINE, 2023, 12 (04): : 4357 - 4362
[39] Propensity Score Matching Analysis to Evaluate Bortezomib/Cyclophosphamide/Dexamethasone and Bortezomib/Thalidomide/Dexamethasone from Real-World Data in Patients with Newly Diagnosed Multiple Myeloma, on Behalf of the Colombian Multiple Myeloma Registry
Martinez-Cordero, Humberto
Abello-Polo, Virginia
Casas, Claudia
Solano, Maria-Helena
Espinosa, Daniel
Perdomo, Ivan
Reyez, Jheremy
Osuna, Monica
Paredes, Viviana
Figueroa, Jair
Gomez, Rigoberto
Jaramillo, Roberto
Gomez, Alvaro
Saavedra, Jose-Domingo
Galvez, Kenny
Quintero, Guillermo
Abenoza, Lina
Gaviria, Lina
Borjas, Yazmin
Idrobo, Henry
Mantilla, William
Sossa, Claudia
Salazar, Luis
Herrera, Juan-Manuel
Guerrero, Paola
Guerrero, Alvaro
Rosales, Carmen
Munevar, Isabel
Bermudez, Carlos-Daniel
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S444 - S445
[40] Impact of Ultra High-risk Genetics on Real-world Outcomes of Transplant-eligible Multiple Myeloma Patients
Panopoulou, Aikaterini
Easdale, Sandra
Ethell, Mark
Nicholson, Emma
Potter, Mike
Giotas, Asterios
Woods, Helena
Thornton, Tracy
Pawlyn, Charlotte
Boyd, Kevin D.
Kaiser, Martin F.
[J]. HEMASPHERE, 2023, 7 (02): : E831

← 1 2 3 4 5 →